Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Treatment approaches to patients with multiple sclerosis and coexisting psoriasis - A longitudinal multicenter observational cohort study.
The gut microbiome in pediatric-onset acquired demyelinating syndromes by myelin oligodendrocyte glycoprotein antibody status.
Genetic Prognostic Factors in Multiple Sclerosis: Key Discoveries and Unmet Needs.
Oligodendrocyte lineage cell-specific GPR17/Gelsolin signaling regulates remyelination and cognitive recovery after subarachnoid hemorrhage.
Auditory Stimulation of Slow-Wave Sleep Promotes Recovery after Brain Injury in an Animal Model.
Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis.
Isolated Arterial Hypertension as a Rare Early Manifestation of Guillain-Barré Syndrome: A Case Report.
Should autologous HSCT be a first-line option in highly active MS? No.
Is supplemental vitamin D useful in the clinically isolated syndrome (CIS) typical of multiple sclerosis?
Real-World Multicenter Cohort Study of Inebilizumab vs Low-Dose Rituximab in Neuromyelitis Optica Spectrum Disorders.
Cerebrospinal Fluid sCD27 as a Biomarker of Neuroinflammatory Disease: A Systematic Review and Meta-Analysis.
Dynamic metabolic programming of monocyte-derived cells defines immunity in CNS disease.
Assessing the reliability and validity of the Italian EQ-5D-5 L in multiple sclerosis: a cross-sectional study.
[Effects of electroacupuncture on HMGB1/RAGE/NF-κB pathway-mediated inflammatory response and reactive astrocyte in Parkinson's disease mice].
Quantitative proteomic profiling of neural cells-specific metabolic reprogramming in response to mitochondrial dysfunction using iMPAQT2.
[Diagnostic and therapeutic challenges of neuromyelitis optica in Côte d'Ivoire: a pediatric case report].
Polyneuropathy in kidney transplant recipients: a cross-sectional study in Groningen, the Netherlands.
Higher disease reactivation risk in women after fingolimod withdrawal.
Plasmalogens in Alzheimer's Disease: A Narrative Review of Dietary Sources, Metabolism, and Neuroprotective Mechanisms.
Research progress of OTUD7B: from structural function and disease mechanisms to clinical translation.
Ravulizumab for relapse prevention in AQP4-IgG-positive neuromyelitis optica spectrum disorder: a 2-year follow-up case report.
Pucker sign in proximal humerus fracture: Case report and review of the literature.
Effects of a Nurse-Led, Acceptance and Commitment-Based Palliative Intervention on the Psychospiritual Well-Being of Patients With Progressive Neurological Diseases: Protocol for a Mixed Methods Study.
Mechanistic Insights and Therapeutic Potential of MCC950 as a NLRP3 Inflammasome Inhibitor in Multiple Sclerosis: A Narrative Review.
Magnetic susceptibility source separation (χ-separation) in quantitative susceptibility mapping.
Pages
« first
‹ previous
…
976
977
978
979
980
981
982
983
984
…
next ›
last »